Steven Jensen, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 515 Aztec Cir, Robinson, TX 76706 Phone: 801-471-5430 |
Dr. Paul A. Friedman, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3600 S Loop 340, Robinson, TX 76706 Phone: 254-523-2222 |
Cameron Collier, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3600 S Loop 340, Robinson, TX 76706 Phone: 512-925-8434 |
News Archive
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rigorous FDA approval process is creating major hurdles for percutaneous heart valve device manufacturers.
The COVID-19 pandemic is exhausting the healthcare resources of many countries, both developed and developing. With the escalating volume of patients who need intensive care and ventilation, breathing masks have become a high-priority item that many medical companies are racing to fill orders for in many parts of the world.
In an effort to insure JCAHO compliance and continue its tradition of providing the highest quality of care to its young patients, the Children's Hospital of Alabama has purchased the iRISecure tissue tracking system from Mobile Aspects.
China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced the receipt of Conformite Europeenne (CE) certification for its Myocardial Infarction and Urine Microalbumin Diagnostic Kits. The CE marking certifies that the two products have met the European Union health and safety standards and are approved for sale in the 27 EU countries and four members of the European Free Trade Association.
After menopause, 6 to 10 million women take hormone therapies, which are often a combination of estrogen and progestin, to replace hormones lost from inactive ovaries. Progestin is a hormone that is used to counteract the potentially negative effects of estrogen therapy on the uterus. In studies sponsored by the National Institutes of Health, evidence has been found that estrogen and progestin in hormone therapies increase the risk of breast cancer in post-menopausal women.
› Verified 1 days ago